Tang, Yang
Liu, Wenli
Wang, Wei
Fidler, Trevor
Woods, Britany
Levine, Ross L.
Tall, Alan R.
Wang, Nan http://orcid.org/0000-0001-9976-0859
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL-118567)
Article History
First Online: 21 February 2020
Compliance with Ethical Standards
:
: Alan R. Tall is a scientific advisory board member for Amgen, Staten Biotech, and Fortico Biotech and a consultant for Janssen, CSL, and the Medicines Company. Ross L. Levine is on the supervisory board of Qiagen and is a scientific advisor to Loxo, Imago, C4 Therapeutics, and Isoplexis which include equity interest. He receives research support from and consulted for Celgene and Roche and has consulted for Lilly, Janssen, Astellas, Morphosys, and Novartis. He has received honoraria from Roche, Lilly, and Amgen for invited lectures and from Gilead for grant reviews.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. This article does not contain any studies with human participants performed by any of the authors.